Post-extinction L-DOPA administration to reduce the return of fear in humans

Access Data

Abstract

The dopamine precursor L-DOPA is a promising adjunct to exposure therapy in anxiety disorders. In two magnetic resonance imaging (MRI) studies we previously showed that a post-extinction administration of L-DOPA reduces the return of fear. However, when aiming to replicate these results outside the MRI scanner, we found weaker effects – albeit with an adjusted paradigm. In order to discern whether the discrepant results can be explained by the experimental environment (in- vs. outside MRI scanner) or the differences in the paradigms, we here replicated a previous MRI paradigm outside the MRI scanner. In total, N=50 male participants underwent fear conditioning on day 1 and extinction on day 2. We tested the effect of post-extinction L-DOPA compared to placebo administration on differential skin conductance responses (SCR) during test on day 3. In contrast to previous findings in the MRI scanner, there was no reduction of differential SCRs after L-DOPA compared to placebo intake at test. Resembling previous findings outside the MRI scanner, there was a significant relationship between differential SCRs at the end of extinction on day 2 and test on day 3 in the L-DOPA group. This relationship did, however, not differ between groups. Summarizing, our results rather speak against an effect of paradigm and in favour of an effect of MRI environment. Contextual arousal, likely to be elevated in the MRI environment, may influence the effect of L-DOPA. These findings call for future work to investigate the interaction between arousal and catecholamines in the context of extinction memory consolidation.

ID 210

Authors

Anna M. V. Gerlicher, Johannes Gutenberg University Medical Center, Mainz, Germany; Utrecht University, Utrecht, The Netherlands Merve Ilhan-Bayrakcı, Leibniz Institute for Resilience Research (LIR), Germany Oliver Tüscher, Leibniz Institute for Resilience Research (LIR), Germany; Johannes Gutenberg University Medical Center, Mainz, Germany Raffael Kalisch, Johannes Gutenberg University Medical Center, Mainz, Germany

Year

2022

DOI of Publication

10.31234/osf.io/rhnsa

Persistent Identifier to Dataset

10.17605/OSF.IO/JV835

Where was the data collected?

Johannes Gutenberg University Medical Center, Mainz, Germany

How to Cite

Gerlicher, A., Ilhan-Bayrakcı, M., Tüscher, O., & Kalisch, R. (2022, March 3). Post-extinction L-DOPA administration to reduce the return of fear in humans. https://doi.org/10.17605/OSF.IO/JV835

Participant Information

Participant Age

Participant Sex

Experimental Group

L-DOPA Group: - participants received L-DOPA (150/37.5 mg Levodopa-Benserazide, ratiophram) on day 2 after extinction Placebor Group: - participants received placebo on day 2 after extinction

Stimuli

Drug Administration

Yes

Conditioning Protocol

Differential

Instructions CS-US Contingencies

Different instructions in different phases

Number of Different US

1

US Modality

electrotactile

Number of Different CS+

1

CS+ 1: Reinforcement Rate (%)

50

CS+ 2: Reinforcement Rate (%)

CS+ 3: Reinforcement Rate (%)

Number of Different CS-

1

CS Modality

visual

Data Collected During MRI

No

Physiological Measures

measured trialwise & untransformed

Skin Conductance Response

Yes No

Skin Conductance Level

No No

Pupil Size

No No

Fear Potentiated Startle/Startle EMG

No No

Heart Rate

No No

Ratings

US Expectancy

Yes

US Intensity Rating

Yes

CS Valence

No

CS Arousal

No

CS Fear

No

CS Stress

No

CS Anxiety

No

Contingency Awareness

No

Questionnaires

State Trait Anxiety Inventory (STAI-S)

State Trait Anxiety Inventory (STAI-T)

Anxiety Sensitivity Index (ASI)